title: Enhanced antibacterial and anti-quorum sensing activities of triclosan by complexation with modified β-cyclodextrins.
abstract: Triclosan (TCS), an antimicrobial agent widely used in consumer and medical products, was complexed with 2-hydroxypropyl-β-cyclodextrin (HPβCD) and methyl-β-cyclodextrin (MβCD). Phase-solubility studies indicated that inclusion complexes of 1:1 stoichiometry were formed and allowed estimation of the associated equilibrium constants and free-energy changes. At the highest cyclodextrin concentrations investigated, an almost 20-fold increase in the apparent water solubility of TCS was determined. Susceptibility tests against Escherichia coli and Staphylococcus aureus showed that the TCS-HPβCD and TCS-MβCD complexes exhibited antibacterial properties higher than those of uncomplexed TCS. The two complexes were also found capable of interfering with cell-to-cell communication mechanisms in the C. violaceum model system relying on N-acylhomoserine lactone autoinducers. The inhibitory activity of TCS increased significantly upon inclusion of the drug in HPβCD or MβCD, with small differences between the two CDs. The results obtained suggest that the investigated complexes could be used for treating infections caused by TCS-susceptible pathogens or for preventing biofilm formation on indwelling medical devices such as catheters, stents and orthopedic implants.
authors.affiliation: Laboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, Rome, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Fidaleo
authors.forename: Antonio
authors.initials: A
authors.lastname: Zuorro
authors.forename: Roberto
authors.initials: R
authors.lastname: Lavecchia
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D018441:Biofilms / Q000187:drug effects; D002861:Chromobacterium / Q000187:drug effects / Q000502:physiology; D055808:Drug Discovery; D004926:Escherichia coli / Q000187:drug effects* / Q000502:physiology; D053038:Quorum Sensing / Q000502:physiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000502:physiology; D014260:Triclosan / Q000737:chemistry* / Q000494:pharmacology; D047392:beta-Cyclodextrins / Q000737:chemistry* / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D047392:beta-Cyclodextrins; D014260:Triclosan
references.citation: J Mol Biol. 1999 Jul 23;290(4):859-65
references.pmid: 10398587
references.citation: Microbiology (Reading). 2006 Apr;152(Pt 4):895-904
references.pmid: 16549654
references.citation: Carbohydr Res. 2008 Oct 13;343(15):2634-40
references.pmid: 18684438
references.citation: Microbiology (Reading). 2007 Dec;153(Pt 12):3923-3938
references.pmid: 18048907
references.citation: Life Sci. 1998;62(20):1901-10
references.pmid: 9600331
references.citation: Nat Rev Microbiol. 2004 Feb;2(2):95-108
references.pmid: 15040259
references.citation: Biophys J. 2003 Aug;85(2):876-85
references.pmid: 12885635
references.citation: J Cosmet Sci. 2003 Nov-Dec;54(6):537-50
references.pmid: 14730370
references.citation: Org Biomol Chem. 2012 Oct 7;10(37):7457-74
references.pmid: 22733439
references.citation: Microbiology (Reading). 1997 Dec;143 ( Pt 12):3703-3711
references.pmid: 9421896
references.citation: J Antimicrob Chemother. 2006 Feb;57(2):266-72
references.pmid: 16339844
references.citation: Eur J Pharm Biopharm. 2008 Jun;69(2):535-45
references.pmid: 18194853
references.citation: Clin Microbiol Rev. 2006 Apr;19(2):403-34
references.pmid: 16614255
references.citation: Curr Drug Deliv. 2008 Jan;5(1):1-6
references.pmid: 18220545
references.citation: Appl Microbiol Biotechnol. 2010 Apr;86(3):813-23
references.pmid: 20165945
references.citation: J Pharm Pharmacol. 2003 Mar;55(3):291-300
references.pmid: 12724033
references.citation: J Pharm Pharmacol. 2005 Oct;57(10):1251-59
references.pmid: 16259753
references.citation: Int J Pharm. 2008 Jun 5;357(1-2):244-51
references.pmid: 18294789
references.citation: Annu Rev Biomed Eng. 2008;10:145-67
references.pmid: 18647113
references.citation: Am J Infect Control. 2000 Apr;28(2):184-96
references.pmid: 10760227
references.citation: Cancer Chemother Pharmacol. 1997;40(6):489-94
references.pmid: 9332463
references.citation: Chem Rev. 1998 Jul 30;98(5):1743-1754
references.pmid: 11848947
references.citation: Adv Skin Wound Care. 2008 Nov;21(11):531-40; quiz 541-2
references.pmid: 18981758
references.citation: J Urol. 2006 Jun;175(6):2331-5
references.pmid: 16697868